Mast cells in allergy and tumor disease

Cancer and IgE: Introducing the Concept of AllergoOncology

Volumn , Issue , 2010, Pages 137-158

  Wasiuk, Anna ^a   De Vries, Victor C ^a   Nowak, Elizabeth C ^a   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900146579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60761-451-7_6     Document Type: Chapter

References (142)

1. Krishnaswamy G. (2005) Mast Cells: Methods and Protocols. Humana Press, New York
2. Yazdanbakhsh, M., A. Van Den Biggelaar, and R. M. Maizels. (2001) Th2 responses without atopy: Immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 22:372-377
3. Lynch, N. R., R. I. Lopez, M. C. Di Prisco-Fuenmayor, I. Hagel, L. Medouze, G. Viana, C. Ortega, and G. Prato. (1987) Allergic reactivity and socio-economic level in a tropical environment. Clin Allergy 17:199-207
4. Masters, S., and E. Barrett-Connor. (1985) Parasites and asthma - predictive or protective? Epidemiol Rev 7:49-58
5. Scrivener, S., H. Yemaneberhan, M. Zebenigus, D. Tilahun, S. Girma, S. Ali, P. McElroy, A. Custovic, A.Woodcock, D. Pritchard, A. Venn, and J. Britton. (2001) Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: A nested case-control study. Lancet 358:1493-1499
6. Molomut, N., D. M. Spain, L. Kreisler, and L. J. Warshaw. (1955) The effect of an allergic inflammatory response in the tumor bed on the fate of transplanted tumors in mice. Cancer Res 15:181-183
7. Augustin, R., S. O'Sullivan, and I. Davies. (1971) Isolation of grass pollen antigens failing to induce IgE reagin formation although capable of inducing IgG antibody formation. Int Arch Allergy Appl Immunol 41:144-147
8. Jacobs, D., J. Landon, M. Houri, and T. G. Merrett. (1972) Circulating levels of immunoglobulin E in patients with cancer. Lancet 2:1059-1061
9. McCormick, D. P., A. J. Ammann, K. Ishizaka, D. G. Miller, and R. Hong. (1971) A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer 27:93-99
10. Ure, D. M. (1969) Negative association between allergy and cancer. Scott Med J 14:51-54
11. Pereira, E. A., D. A. Silva, J. P. Cunha-Junior, K. C. Almeida, R. Alves, S. J. Sung, and E. A. Taketomi. (2005) IgE, IgG1, and IgG4 antibody responses to Blomia tropicalis in atopic patients. Allergy 60:401-406
12. Maurer, M., T. Theoharides, R. D. Granstein, S. C. Bischoff, J. Bienenstock, B. Henz, P. Kovanen, A. M. Piliponsky, N. Kambe, H. Vliagoftis, F. Levi-Schaffer, M. Metz, Y. Miyachi, D. Befus, P. Forsythe, Y. Kitamura, and S. Galli. (2003) What is the physiological function of mast cells? Exp Dermatol 12:886-910
13. Algermissen, B., B. Hermes, I. Feldmann-Boeddeker, F. Bauer, and B. M. Henz. (1999) Mast cell chymase and tryptase during tissue turnover: Analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol 8: 193-198
14. Kataoka, T. R., N. Komazawa, E. Morii, K. Oboki, and T. Nakano. (2005) Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression. Blood 105:1016-1020
15. Kaplan, M. H., A. L. Wurster, and M. J. Grusby. (1998) A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med. 188:1191-1196
16. Yoshimoto, T., H. Tsutsui, K. Tominaga, K. Hoshino, H. Okamura, S. Akira, W. E. Paul, and K. Nakanishi. (1999) IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 96:13962-13966
17. Grabbe, S., and T. Schwarz. (1998) Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37-44
18. Takeshita, K., T. Yamasaki, S. Akira, F. Gantner, and K. B. Bacon. (2004) Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16:685-695
19. Yokozeki, H., M. Ghoreishi, S. Takagawa, K. Takayama, T. Satoh, I. Katayama, K. Takeda, S. Akira, and K. Nishioka. (2000) Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191:995-1004
20. Askenase, P. W., M. Szczepanik, A. Itakura, C. Kiener, and R. A. Campos. (2004) Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. Trends Immunol 25:441-449
21. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. (2005) Mast cells as 'tunable' effector and immunoregulatory cells: Recent advances. Annu Rev Immunol 23:749-786
22. Jawdat, D. M., G. Rowden, and J. S. Marshall. (2006) Mast cells have a pivotal role in TNFindependent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 177:1755-1762
23. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. (1996) Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397-1411
24. Hwang, J. M., J. Yamanouchi, P. Santamaria, and P. Kubes. (2004) A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J Exp Med 199:1223-1234
25. Van Loveren, H., K. Kato, R. Meade, D. R. Green, M. Horowitz, W. Ptak, and P. W. Askenase. (1984) Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol 133:2402-2411
26. Van Loveren, H., R.Meade, and P.W. Askenase. (1983) An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med 157:1604-1617
27. Norman, M. U., J. Hwang, S. Hulliger, C. S. Bonder, J. Yamanouchi, P. Santamaria, and P. Kubes. (2008) Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am J Pathol 172:1638-1649
28. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. (2000) Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192:1441-1452
29. Gordon, J. R., and S. J. Galli. (1990) Mast cells as a source of both preformed and immunologically inducible TNF-Alpha/cachectin. Nature 346:274-276
30. Gordon, J. R., and S. J. Galli. (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-Alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-Alpha during IgE-dependent biological responses. J Exp Med 174:103-107
31. Bryce, P. J., M. L.Miller, I.Miyajima, M. Tsai, S. J. Galli, and H. C. Oettgen. (2004) Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20:381-392
32. Jawdat, D. M., E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall. (2004) IgEmediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173: 5275-5282
33. Suto, H., S. Nakae, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. (2006) Mast cell-Associated TNF promotes dendritic cell migration. J Immunol 176:4102-4112
34. Roelandt, T., C. Heughebaert, and J. P. Hachem. (2008) Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 128:1878-1880
35. Schittek, B., M. Paulmann, I. Senyurek, and H. Steffen. (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8: 135-143
36. Schmid-Wendtner, M. H., and H. C. Korting. (2006) The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 19:296-302
37. Nilsson, G., M. Johnell, C. H. Hammer, H. L. Tiffany, K. Nilsson, D. D. Metcalfe, A. Siegbahn, and P. M. Murphy. (1996) C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693-1698
38. Heib, V., M. Becker, T. Warger, G. Rechtsteiner, C. Tertilt, M. Klein, T. Bopp, C. Taube, H. Schild, E. Schmitt, and M. Stassen. (2007) Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110:946-953
39. McCurdy, J. D., T. J. Lin, and J. S. Marshall. (2001) Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70:977-984
40. Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. (2001) Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167:2250-2256
41. Varadaradjalou, S., F. Feger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. (2003) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33:899-906
42. Liu, Y. J. (2006) Thymic stromal lymphopoietin: Master switch for allergic inflammation. J Exp Med 203:269-273
43. Ziegler, S. F., and Y. J. Liu. (2006) Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7:709-714
44. Miyata, M., K. Hatsushika, T. Ando, N. Shimokawa, Y. Ohnuma, R. Katoh, H. Suto, H. Ogawa, K. Masuyama, and A. Nakao. (2008) Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 38:1487-1492
45. Mazzoni, A., R. P. Siraganian, C. A. Leifer, and D. M. Segal. (2006) Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol 177: 3577-3581
46. McIlroy, A., G. Caron, S. Blanchard, I. Fremaux, D. Duluc, Y. Delneste, A. Chevailler, and P. Jeannin. (2006) Histamine and prostaglandin E up-regulate the production of Th2-Attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. Immunology 117:507-516
47. Theiner, G., A. Gessner, and M. B. Lutz. (2006) The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology 211:463-472
48. Galli, S. J., S. Nakae, andM. Tsai. (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135-142
49. Galli, S. J., M. Grimbaldeston, andM. Tsai. (2008) Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity. Nat Rev Immunol 8:478-486
50. Metz, M., M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli. (2007) Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217: 304-328
51. Sayed, B. A., and M. A. Brown. (2007) Mast cells as modulators of T-cell responses. Immunol Rev 217:53-64
52. Stelekati, E., Z. Orinska, and S. Bulfone-Paus. (2007) Mast cells in allergy: Innate instructors of adaptive responses. Immunobiology 212:505-519
53. Mekori, Y. A. (2004) The mastocyte: The 'other' inflammatory cell in immunopathogenesis. J Allergy Clin Immunol 114:52-57
54. Tanzola, M. B., M. Robbie-Ryan, C. A. Gutekunst, and M. A. Brown. (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171:4385-4391
55. Wang, H. W., N. Tedla, A. R. Lloyd, D. Wakefield, and P. H. McNeil. (1998) Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 102:1617-1626
56. Frandji, P., C. Oskeritzian, F. Cacaraci, J. Lapeyre, R. Peronet, B. David, J. G. Guillet, and S. Mecheri. (1993) Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151:6318-6328
57. Koch, N., and A. W. Harris. (1984) Differential expression of the invariant chain in mouse tumor cells: Relationship to B lymphoid development. J Immunol 132:12-15
58. Malaviya, R., N. J. Twesten, E. A. Ross, S. N. Abraham, and J. D. Pfeifer. (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490-1496
59. Wong, G. H., I. Clark-Lewis, J. L. McKimm-Breschkin, and J. W. Schrader. (1982) Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci USA 79:6989-6993
60. Frandji, P., C. Tkaczyk, C. Oskeritzian, B. David, C. Desaymard, and S. Mecheri. (1996) Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 26:2517-2528
61. Nakae, S., H. Suto, M. Iikura, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. (2006) Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176:2238-2248
62. Frandji, P., C. Tkaczyk, C. Oskeritzian, J. Lapeyre, R. Peronet, B. David, J. G. Guillet, and S. Mecheri. (1995) Presentation of soluble antigens by mast cells: Upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 163:37-46
63. Walsh, L. J. (1995) Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumor necrosis factor-Alpha. Immunol Cell Biol 73:226-233
64. Meng, H., M. J. Marchese, J. A. Garlick, A. Jelaska, J. H. Korn, J. Gailit, R. A. Clark, and B. L. Gruber. (1995) Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. J Invest Dermatol 105:789-796
65. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. (2003) Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4:1199-1205
66. Zhuang, X., A. J. Silverman, and R. Silver. (1996) Brain mast cell degranulation regulates blood-brain barrier. J Neurobiol 31:393-403
67. Marshall, J. S., C. A. King, and J. D. McCurdy. (2003) Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 9:11-24
68. Mekori, Y. A., and D. D. Metcalfe. (1999) Mast cell-T cell interactions. J Allergy Clin Immunol 104:517-523
69. Jutel, M., T.Watanabe, S. Klunker, M. Akdis, O. A. Thomet, J.Malolepszy, T. Zak-Nejmark, R. Koga, T. Kobayashi, K. Blaser, and C. A. Akdis. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420-425
70. Holgate, S. T. (2008) Pathogenesis of asthma. Clin Exp Allergy 38:872-897
71. Cairns, J. A., and A. F. Walls. (1996) Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156:275-283
72. Compton, S. J., J. A. Cairns, S. T. Holgate, and A. F. Walls. (1998) The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161: 1939-1946
73. Berger, P., D.W. Perng, H. Thabrew, S. J. Compton, J. A. Cairns, A. R.McEuen, R. Marthan, J. M. Tunon De Lara, and A. F. Walls. (2001) Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 91:1372-1379
74. Okumura, S., H. Sagara, T. Fukuda, H. Saito, and Y. Okayama. (2005) FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J Allergy Clin Immunol 115:272-279
75. Wang, S. W., C. K. Oh, S. H. Cho, G. Hu, R. Martin, S. Demissie-Sanders, K. Li, M. Moyle, and Z. Yao. (2005) Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. J Allergy Clin Immunol 115:287-294
76. Woodman, L., S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling. (2008) Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol 181:5001-5007
77. Black, P. N., R. W. Fuller, G. W. Taylor, P. J. Barnes, and C. T. Dollery. (1989) Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. Thorax 44:491-495
78. Rajah, R., S. E. Nunn, D. J. Herrick, M. M. Grunstein, and P. Cohen. (1996) Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am J Physiol 271:L1014-1022
79. Dunnill, M. S. (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27-33
80. Li, X., and J. W. Wilson. (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156:229-233
81. Orsida, B. E., X. Li, B. Hickey, F. Thien, J.W.Wilson, and E. H.Walters. (1999) Vascularity in asthmatic airways: Relation to inhaled steroid dose. Thorax 54:289-295
82. Redington, A. E., W. R. Roche, J. Madden, A. J. Frew, R. Djukanovic, S. T. Holgate, and P. H. Howarth. (2001) Basic fibroblast growth factor in asthma: Measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 107:384-387
83. Horiuchi, T., and P. F. Weller. (1997) Expression of vascular endothelial growth factor by human eosinophils: Upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 17:70-77
84. Richter, A., S. M. Puddicombe, J. L. Lordan, F. Bucchieri, S. J. Wilson, R. Djukanovic, G. Dent, S. T. Holgate, and D. E. Davies. (2001) The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 25:385-391
85. Lee, C. G., H. Link, P. Baluk, R. J. Homer, S. Chapoval, V. Bhandari, M. J. Kang, L. Cohn, Y. K. Kim, D. M. McDonald, and J. A. Elias. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095-1103
86. Puxeddu, I., D. Ribatti, E. Crivellato, and F. Levi-Schaffer. (2005) Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116:531-536
87. Amini, R. M., K. Aaltonen, H. Nevanlinna, R. Carvalho, L. Salonen, P. Heikkila, and C. Blomqvist. (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 7:165
88. Lachter, J., M. Stein, C. Lichtig, S. Eidelman, and M. Munichor. (1995) Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 38:290-293
89. Sivridis, E., A. Giatromanolaki, and M. I. Koukourakis. (2003) The vascular network of tumours - what is it not for? J Pathol 201:173-180
90. Goldmann, E. (1908) The growth of malignant disease in man and the lower animals, with special reference to the Vascular system. Proc R Soc Med 1:1-13
91. Starkey, J. R., P. K. Crowle, and S. Taubenberger. (1988) Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48-52
92. Coussens, L. M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb, G. H. Caughey, and D. Hanahan. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397
93. Gounaris, E., S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, V. P. Rao, T. Poutahidis, R. Weissleder, K. M. McNagny, and K. Khazaie. (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104:19977-19982
94. Soucek, L., E. R. Lawlor, D. Soto, K. Shchors, L. B. Swigart, and G. I. Evan. (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211-1218
95. Conti, P., X. Pang, W. Boucher, R. Letourneau, M. Reale, R. C. Barbacane, J. Thibault, and T. C. Theoharides. (1997) Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120-4127
96. Conti, P., M. Reale, R. C. Barbacane, R. Letourneau, and T. C. Theoharides. (1998) Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: Lack of effects in genetically mast cell-deficient W/WV mice. FASEB J 12:1693-1700
97. Crivellato, E., B. Nico, and D. Ribatti. (2008) Mast cells and tumour angiogenesis: New insight from experimental carcinogenesis. Cancer Lett 269:1-6
98. Brew, R., J. S. Erikson, D. C. West, A. R. Kinsella, J. Slavin, and S. E. Christmas. (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78-85
99. Salven, P., K. Hattori, B. Heissig, and S. Rafii. (2002) Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16:1471-1473
100. Hong, D. S., L. S. Angelo, and R. Kurzrock. (2007) Interleukin-6 and its receptor in cancer: Implications for translational therapeutics. Cancer 110:1911-1928
101. Almholt, K., and M. Johnsen. (2003) Stromal cell involvement in cancer. Recent Results Cancer Res 162:31-42
102. Esposito, P., N. Chandler, K. Kandere, S. Basu, S. Jacobson, R. Connolly, D. Tutor, and T. C. Theoharides. (2002) Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303: 1061-1066
103. Ch'ng, S., R. A.Wallis, L. Yuan, F. P. Davis, and S. T. Tan. (2006) Mast cells and cutaneous malignancies. Mod Pathol 19:149-159
104. Beil, W. J., W. Fureder, H. Wiener, K. Grossschmidt, U. Maier, A. Schedle, H. C. Bankl, K. Lechner, and P. Valent. (1998) Phenotypic and functional characterization of mast cells derived from renal tumor tissues. Exp Hematol 26:158-169
105. Wooley, D., and Norrby K. (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv Biosci 89:71-115
106. Ribatti, D., E. Crivellato, A.M. Roccaro, R. Ria, and A. Vacca. (2004) Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 34:1660-1664
107. Molin, D., A. Edstrom, I. Glimelius, B. Glimelius, G. Nilsson, C. Sundstrom, and G. Enblad. (2002) Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 119:122-124
108. Costa, J. J., G. D. Demetri, T. J. Harrist, A. M. Dvorak, D. F. Hayes, E. A. Merica, D. M. Menchaca, A. J. Gringeri, L. B. Schwartz, and S. J. Galli. (1996) Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681-2686
109. Coussens, L. M., and Z. Werb. (2002) Inflammation and cancer. Nature 420:860-867
110. Sinnamon, M. J., K. J. Carter, L. P. Sims, B. Lafleur, B. Fingleton, and L. M. Matrisian. (2008) A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29: 880-886
111. Gooch, J. L., A. V. Lee, and D. Yee. (1998) Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res 58:4199-4205
112. Theoharides, T. C., and P. Conti. (2004) Mast cells: The Jekyll and Hyde of tumor growth. Trends Immunol 25:235-241
113. Wedemeyer, J., and S. J. Galli. (2005) Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Invest 85:388-396
114. Cuenca, A., F. Cheng, and H. Wang. (2003) Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: Dominant role of cross-tolerance to tumor antigens. Cancer Res 63:9007-9015
115. Gajewski, T. F., Y. Meng, C. Blank, I. Brown, A. Kacha, J. Kline, and H. Harlin. (2006) Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213: 131-145
116. Ochsenbein, A. F., P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R. M. Zinkernagel. (1999) Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA 96:2233-2238
117. Sotomayor, E. M., I. Borrello, D. M. Rattis, A. G. Cuena, J. Abrams, K. Staveley-O'Carroll, and H. I. Levitsky. (2001) Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. Blood 98:1070-1077
118. Zou, W. (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 6:295-307
119. Theoharides, T. C., D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros. (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217:65-78
120. Pos, Z., Z. Wiener, P. Pocza, M. Racz, S. Toth, Z. Darvas, V. Molnar, H. Hegyesi, and A. Falus. (2008) Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res 68:1997-2005
121. Cianchi, F., M. C. Vinci, and E. Masini. (2008) Histamine in cancer: The dual faces of the coin. Cancer Biol Ther 7:36-37
122. Hart, P. H., M. A. Grimbaldeston, G. J. Swift, A. Jaksic, F. P. Noonan, and J. J. Finlay-Jones. (1998) Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187: 2045-2053
123. Depinay, N., F. Hacini, W. Beghdadi, R. Peronet, and S. Mecheri. (2006) Mast celldependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176:4141-4146
124. Aune, T. M., H. W. Golden, K. M. McGrath. (1994) Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 153:489-498
125. Laberge, S., W.W. Cruikshank, D. J. Beer, and D. M. Center. (1996) Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 156:310-315
126. León-Ponte, M., G. P. Ahern, and P. J. O'Connell. (2007) Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109:3139-3146
127. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704
128. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, T. B. Strom, X. X. Zheng, and R. J. Noelle. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002
129. Samoszuk, M., and M. A. Corwin. (2003) Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec). Int J Cancer 106:647-652
130. Ribatti, D., A. Vacca, B. Nico, F. Quondamatteo, R. Ria, M. Minischetti, A. Marzullo, R. Herken, L. Roncali, and F. Dammacco. (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451-455
131. Fisher, E. R., S. M. Paik, H. Rockette, J. Jones, R. Caplan, and B. Fisher. (1989) Prognostic significance of eosinophils and mast cells in rectal cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol 20:159-163
132. Ribatti, D., M. G. Ennas, A. Vacca, F. Ferreli, B. Nico, S. Orru, and P. Sirigu. (2003) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33:420-425
133. Iamaroon, A., S. Pongsiriwet, S. Jittidecharaks, K. Pattanaporn, S. Prapayasatok, and S. Wanachantararak. (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 32:195-199
134. Imada, A., N. Shijubo, H. Kojima, and S. Abe. (2000) Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15:1087-1093
135. Ribatti, D., B. Nico, C. Maxia, V. Longo, D. Murtas, D. Mangieri, M. T. Perra, M. De Giorgis, F. Piras, E. Crivellato, and P. Sirigu. (2007) Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 11:585-589
136. Samoszuk, M., E. Kanakubo, and J. K. Chan. (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 15:121
137. Aaltomaa, S., P. Lipponen, S. Papinaho, and V.M. Kosma. (1993) Mast cells in breast cancer. Anticancer Res 13:785-788
138. Dabiri, S., D. Huntsman, N. Makretsov, M. Cheang, B. Gilks, C. Bajdik, K. Gelmon, S. Chia, andM. Hayes. (2004) The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol 17:690-695
139. Chan, J. K., A. Magistris, V. Loizzi, F. Lin, J. Rutgers, K. Osann, P. J. DiSaia, and M. Samoszuk. (2005) Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol 99:20-25
140. Tuna, B., K. Yorukoglu, M. Unlu, M. U. Mungan, and Z. Kirkali. (2006) Association of mast cells with microvessel density in renal cell carcinomas. Eur Urol 50:530-534
141. Fisher, E. R., R. Sass, G. Watkins, J. Johal, and B. Fisher. (1985) Tissue mast cells in breast cancer. Breast Cancer Res Treat 5:285-291
142. Welsh, T. J., R. H. Green, D. Richardson, D. A. Waller, K. J. O'Byrne, and P. Bradding. (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23:8959-8967